The three formulas the calculator uses: Concentration (mg/mL) = vial mg bacteriostatic water mL Units to draw = (target mcg (vial mg 1000)) water mL 100 Doses per vial = (vial mg 1000) target mcg, rounded down A 5 mg vial reconstituted with 2 mL of bacteriostatic water is 2.5 mg/mL, or 25 mcg per unit
Mochi Health serves all 50 states with no restrictions
Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
IL-6-mediated hepatocyte production is the primary source of plasma and urine neutrophil gelatinase-associated lipocalin during acute kidney injury
Call emergency services or seek emergency care for: Trouble breathing, swallowing, or speaking Generalized muscle weakness or inability to hold up the head Wheezing, throat tightness, widespread hives, facial/tongue swelling, or faintness suggesting a serious allergic reaction New severe neurologic symptoms such as slurred speech, profound weakness, confusion, seizure, or loss of consciousness Urgent eye or headache evaluation may be needed Seek prompt medical assessment for a sudden severe worst headache, headache with weakness or speech change, persistent double or blurred vision, severe eye pain, a red light-sensitive eye, or inability to close the eye
In December 2017, glycopyrrolate (GLY) inhalation solution (Lonhala [Sunovion Pharmaceuticals, Inc., Marlborough, MA, USA]) 25 g twice daily (BID) delivered via the eFlow Closed System (CS) Nebulizer (Magnair [PARI Pharma GmbH, Starnberg, Germany]) was approved by the US Food and Drug Administration (FDA) for the long-term maintenance treatment of airflow obstruction in patients with moderate-to-very-severe COPD (referred henceforth as nebulized GLY) 6
